# SELLAS Life Sciences posts $10.1M Q3 loss as pivotal leukemia trial results approach

> HelixNews · Web page: https://helixnews.one/story/2490550 · All pages for agents: https://helixnews.one/llms.txt

1 outlet covering · First listed: Crypto Briefing, Nov 12, 2026, 3:26 PM · Read it: <https://cryptobriefing.com/sellas-life-sciences-earnings-q3-2026-11/>

SELLAS' financial loss underscores the high stakes of its leukemia trials, potentially impacting future funding and strategic directions.

## Who's covering it

In the order they published:

- Nov 12, 2026, 3:26 PM: [SELLAS Life Sciences posts $10.1M Q3 loss as pivotal leukemia trial results approach](<https://cryptobriefing.com/sellas-life-sciences-earnings-q3-2026-11/>) — Crypto Briefing (Specialist)
  SELLAS' financial loss underscores the high stakes of its leukemia trials, potentially impacting future funding and strategic directions.